Selected Drugs Clear All
MultiCheck Results
- 0
Interaction
Additional Considerations |
||
|
erdafitinib
in Balversa
|
||
|
avoid combo with drugs containing phosphate as an inactive ingredient during erdafitinib initial dose titration period; otherwise, monitor phosphate; combo may interfere with erdafitinib dose titration, incr. risk of hyperphosphatemia |
||